Liquid biopsy test can detect 30 types of canine cancer, study showsApril 27, 2022Veterinarians can now benefit from a new tool able to assist in early detection and diagnosis of 30 types of canine cancer.
SPONSORED CONTENTProtect your patients from the start.Simparica Trio (sarolaner, moxidectin, and pyrantel chewable tablets) is the first monthly preventative of its kind. Combining three ingredients for month-long protection. + Learn more
$10M financing helps marry canine and human cancer techniquesNovember 6, 2020One Health Company has received sizable funding to help advance precision medicine in canine oncology.
TGen, Ethos develop diagnosis test for canine lymphomaMay 24, 2019A new test may assist veterinarians in more accurately diagnosing canine lymphoma. Developed by Ethos Veterinary Health, Ethos Discovery, and the Translational Genomics Research Institute (TGen), the test is based on the results of a study that analyzed 180 dogs with cancer. The teams used their test, ePARR, to confirm first whether the dogs in the study had lymphoma and then determined what type they had. Results indicate the test was more than 90 percent accurate among a range of lymphoma sample types. "An ongoing need exists for robust validation of molecular diagnostics in veterinary medicine. This study is an example of exhaustive validation of one such molecular test," says Will Hendricks, PhD, assistant professor in TGen's Integrated Cancer Genomics Division and one of the study's senior coauthors. "Overall, ePARR is more than 90 percent accurate across sample types and diagnostic settings." The researchers say not only could molecular-level investigations into dog DNA improve the health of dogs with cancer, but it could help understand cancer in humans, too.
Petco Foundation, Blue Buffalo invest $15 million in pet cancer researchMay 14, 2019Petco Foundation and Blue Buffalo announced they have invested $15 million in pet cancer research and treatment since starting the Pet Cancer Awareness campaign in 2010. Not only that, their goal is to raise an additional $2.6 million this year to support innovative programs at veterinary oncology universities in the U.S., and to continue to help owners afford the cost of cancer treatments for their pets. "Blue Buffalo has been committed to finding a cure for pet cancer since our inception," says the company's vice president, David Petrie. "We are excited about collaborative efforts, together with Petco and the Petco Foundation, to raise funds for research, increase awareness of cancer warning signs, and help pet parents with the cost of pet cancer treatment." Funds raised in the campaign will go toward new investments such as Oklahoma State University's Center of Veterinary Health Sciences, which is focused on ultrasound cancer treatment. The therapy would provide a noninvasive, nontoxic alternative to surgery, radiation, and chemotherapy. Further, additional investments to 10 university veterinary oncology centers will help assist owners cover the cost of cancer treatments for their pets. Petco Foundation will also be launching a fund to help animal welfare organizations offset cancer …
